Variant report
Variant | nsv827894 |
---|---|
Chromosome Location | chr17:15044311-15058744 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs367811480 | chr17:15048611-15048612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs544772796 | chr17:15048661-15048662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564749276 | chr17:15048678-15048679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs527536802 | chr17:15048691-15048692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs201811466 | chr17:15048705-15048706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552352308 | chr17:15048712-15048713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs560930631 | chr17:15048732-15048733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7217105 | chr17:15048783-15048784 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs58073472 | chr17:15048826-15048827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549826075 | chr17:15048837-15048838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188408800 | chr17:15048856-15048857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs138327659 | chr17:15048859-15048860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs144053474 | chr17:15048893-15048894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570652217 | chr17:15048935-15048936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192693124 | chr17:15048937-15048938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184685860 | chr17:15048954-15048955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535321116 | chr17:15048978-15048979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555000373 | chr17:15048983-15048984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs568423217 | chr17:15048994-15048995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs537025674 | chr17:15048995-15048996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190015310 | chr17:15049041-15049042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs541511188 | chr17:15049086-15049087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576888670 | chr17:15049098-15049099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs58228877 | chr17:15049119-15049120 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs572187226 | chr17:15049145-15049146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181407012 | chr17:15049153-15049154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs578041664 | chr17:15049159-15049160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs112923829 | chr17:15049191-15049192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs145586607 | chr17:15050213-15050214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185038863 | chr17:15050217-15050218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191619801 | chr17:15050296-15050297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs10459905 | chr17:15050323-15050324 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs181292490 | chr17:15050397-15050398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs148648513 | chr17:15050448-15050449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555421092 | chr17:15050465-15050466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs370903757 | chr17:15050487-15050488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs79807056 | chr17:15050491-15050492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565857779 | chr17:15050508-15050509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs142059220 | chr17:15050531-15050532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs10459906 | chr17:15050582-15050583 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs186342039 | chr17:15050588-15050589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs577234776 | chr17:15050598-15050599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs545785026 | chr17:15050692-15050693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs8065662 | chr17:15050715-15050716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572806820 | chr17:15050729-15050730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs10459907 | chr17:15050737-15050738 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs578155645 | chr17:15050742-15050743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs114313801 | chr17:15050771-15050772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs151130665 | chr17:15050775-15050776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs140239593 | chr17:15050782-15050783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21509527 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Autism | 17322880 | CNVD |
Hereditary neuropathy with liability to pressure palsy | 19521722 | CNVD |
Schizophrenia | 19571808 | CNVD |
Schizophrenia | 19955444 | CNVD |
Charcot-marie-tooth disease | 18787571 | CNVD |
Breast cancer | 20409316 | CNVD |
Autism | 18414403 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Peripheral neuropathy | 21193943 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 22958593 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Breast cancer | 21858162 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Schizophrenia | 20967226 | CNVD |
Autism | 18522746 | CNVD |
Epilepsy | 21635232 | CNVD |
Autism | 22543975 | CNVD |
Obesity | 20622171 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17142309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:15048600-15049200 | Enhancers | Fetal Stomach | stomach |
2 | chr17:15050200-15050800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr17:15057600-15059000 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr17:15058000-15058800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
5 | chr17:15058000-15060800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
6 | chr17:15058000-15061200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr17:15058200-15058600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
8 | chr17:15058200-15058800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr17:15058200-15058800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr17:15058200-15059200 | Enhancers | Osteobl | bone |
11 | chr17:15058200-15059600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
12 | chr17:15058400-15058800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr17:15058400-15059200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr17:15058400-15059400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
15 | chr17:15058600-15059400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr17:15058600-15060000 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |